American Journal of Roentgenology, Vol 167, 1017-1021, Copyright © 1996 by American Roentgen Ray Society

ARTICLES

Hepatic lobar atrophy: association with ipsilateral portal vein obstruction

LE Hann, GI Getrajdman, KT Brown, AM Bach, JB Teitcher, Y Fong and LH Blumgart
Department of Radiology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

OBJECTIVE: This study was performed to evaluate the association between hepatic lobar atrophy, bile duct obstruction, and portal vein obstruction. MATERIALS AND METHODS: Thirty cases of hepatic lobar atrophy identified on angiography with CT during arterial portography from August 1992 to March 1995 were retrospectively reviewed by two independent observers. Cases were evaluated for vascular patency and bile duct obstruction. Malignant diagnoses were present in 28 of 30 patients. RESULTS: Twenty-two patients (73%) had atrophy in the left lobe and eight patients (27%) had right lobar atrophy. Portal vein obstruction was unilateral and confined to the atrophic lobe in 26 patients (87%). In contrast, bile duct obstruction was bilateral in 23 patients (77%) and in only four patients (13%) was it isolated to the atrophic lobe. The correlation between atrophy and portal vein obstruction was significant, with 90% sensitivity, 97% specificity, and 96% positive predictive value (p < .00001). For the correlation between atrophy and biliary obstruction, the sensitivity of angiography with CT during arterial portography was 90%, specificity was 23%, and positive predictive value was 54% (p = .17). CONCLUSION: Hepatic lobar atrophy usually occurs in the setting of combined biliary and portal vein obstruction. A significant correlation exists between hepatic lobar atrophy and ipsilateral portal vein obstruction.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. M. Slattery and D. V. Sahani What Is the Current State-of-the-Art Imaging for Detection and Staging of Cholangiocarcinoma? Oncologist, September 1, 2006; 11(8): 913 - 922. [Abstract] [Full Text] [PDF]

				H. Y. Lee, S. H. Kim, J. M. Lee, S.-W. Kim, J.-Y. Jang, J. K. Han, and B. I. Choi Preoperative Assessment of Resectability of Hepatic Hilar Cholangiocarcinoma: Combined CT and Cholangiography with Revised Criteria Radiology, April 1, 2006; 239(1): 113 - 121. [Abstract] [Full Text] [PDF]

				M. Ijichi, T. Takayama, H. Toyoda, K. Sano, K. Kubota, and M. Makuuchi Randomized Trial of the Usefulness of a Bile Leakage Test During Hepatic Resection Arch Surg, December 1, 2000; 135(12): 1395 - 1400. [Abstract] [Full Text] [PDF]

				P. C. de Groen, G. J. Gores, N. F. LaRusso, L. L. Gunderson, and D. M. Nagorney Biliary Tract Cancers N. Engl. J. Med., October 28, 1999; 341(18): 1368 - 1378. [Full Text] [PDF]

				C. B. Winston, L. H. Schwartz, Y. Fong, L. H. Blumgart, and D. M. Panicek Hepatocellular Carcinoma: MR Imaging Findings in Cirrhotic Livers and Noncirrhotic Livers Radiology, January 1, 1999; 210(1): 75 - 79. [Abstract] [Full Text]